Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Impact of sitagliptin on endometrial mesenchymal stem-like progenitor cells : a randomised, double-blind placebo-controlled feasibility trial

Tools
- Tools
+ Tools

Tewary, Shreeya, Lucas, Emma S., Fujihara, Risa, Kimani, Peter K., Polanco, Angela, Brighton, Paul (Paul J.), Muter, Joanne, Fishwick, Katherine, Da Costa, Maria José Minhoto Diniz, Ewington, Lauren J., Lacey, Lauren, Takeda, Satoru, Brosens, Jan J. and Quenby, Siobhan (2020) Impact of sitagliptin on endometrial mesenchymal stem-like progenitor cells : a randomised, double-blind placebo-controlled feasibility trial. EBioMedicine, 51 . 102597. doi:10.1016/j.ebiom.2019.102597 ISSN 2352-3964.

[img]
Preview
PDF
WRAP-impact-sitagliptin-endometrial-mesenchymal-stem-like-progenitor-cells-Quenby-2020.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution Non-commercial No Derivatives 4.0.

Download (708Kb) | Preview
Official URL: http://dx.doi.org/10.1016/j.ebiom.2019.102597

Request Changes to record.

Abstract

Background:
Recurrent pregnancy loss (RPL) is associated with the loss of endometrial mesenchymal stem-like progenitor cells (eMSC). DPP4 inhibitors may increase homing and engraftment of bone marrow-derived cells to sites of tissue injury. Here, we evaluated the effect of the DPP4 inhibitor sitagliptin on eMSC in women with RPL, determined the impact on endometrial decidualization, and assessed the feasibility of a full-scale clinical trial.
Methods:
A double-blind, randomised, placebo-controlled feasibility trial on women aged 18 to 42 years with a history of 3 or more miscarriages, regular menstrual cycles, and no contraindications to sitagliptin. Thirty-eight subjects were randomised to either 100 mg sitagliptin daily for 3 consecutive cycles or identical placebo capsules. Computer generated, permuted block randomisation was used to allocate treatment packs. Colony forming unit (CFU) assays were used to quantify eMSC in midluteal endometrial biopsies. The primary outcome measure was CFU counts. Secondary outcome measures were endometrial thickness, study acceptability, and first pregnancy outcome within 12 months following the study. Tissue samples were subjected to explorative investigations.
Findings:
CFU counts following sitagliptin were higher compared to placebo only when adjusted for baseline CFU counts and age (RR: 1.52, 95% CI: 1.32–1.75, P<0.01). The change in CFU count was 1.68 in the sitagliptin group and 1.08 in the placebo group. Trial recruitment, acceptability, and drug compliance were high. There were no serious adverse events. Explorative investigations showed that sitagliptin inhibits the expression of DIO2, a marker gene of senescent decidual cells.
Interpretation:
Sitagliptin increases eMSCs and decreases decidual senescence. A large-scale clinical trial evaluating the impact of preconception sitagliptin treatment on pregnancy outcome in RPL is feasible and warranted.
Funding:
Tommy's Baby Charity.
Clinical trial registration:
EU Clinical Trials Register no. 2016-001120-54.

Item Type: Journal Article
Subjects: Q Science > QH Natural history
Q Science > QP Physiology
R Medicine > R Medicine (General)
R Medicine > RG Gynecology and obstetrics
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Pregnancy -- Complications -- Research, Miscarriage -- Research, Endometrium, Stem cells, Decidua, Clinical trials
Journal or Publication Title: EBioMedicine
Publisher: Elsevier BV
ISSN: 2352-3964
Official Date: 9 January 2020
Dates:
DateEvent
9 January 2020Published
10 December 2019Accepted
Volume: 51
Article Number: 102597
DOI: 10.1016/j.ebiom.2019.102597
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 10 January 2020
Date of first compliant Open Access: 20 January 2020
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
UNSPECIFIEDTommy's Baby Charityhttp://dx.doi.org/10.13039/501100000306
UNSPECIFIEDJuntendo Universityhttp://dx.doi.org/10.13039/501100005731
UNSPECIFIEDNIHR Coventry and Warwickshire Clinical Research Facilityhttps://www.uhcw.nhs.uk/leading-research/about-us/our-facilities/nihr-coventry-warwickshire-clinical-research-facility/

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us